X4 Pharmaceuticals (XFOR) Misses Q3 EPS by 69c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 EPS of ($0.69). Revenue for the quarter came in at $1.76 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%
• Active options: NVDA TSLA SPCX AAPL AMZN MU INTC NFLX MSFT PLTR